The Food and Drug Administration (FDA) has initiated a Class II recall, designated D-0362-2026, for ACME UNITED CORPORATION's BZK Antiseptic Towelettes. The recall is due to Current Good Manufacturing Practice (CGMP) deviations identified in the manufacturing process. The affected product is described as BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%) in 5"x7" size, packaged in bulk 1,000-count units, and distributed nationwide.

This recall signifies a critical compliance issue for ACME UNITED CORPORATION and potentially other entities involved in the supply chain. Companies involved in drug manufacturing must ensure strict adherence to CGMP regulations to prevent such deviations. While the document does not specify a compliance deadline for the recall itself, the ongoing nature and the reason for recall (CGMP deviations) indicate a need for immediate corrective actions by the manufacturer and potentially distributors to manage the affected product and address the underlying manufacturing deficiencies.